Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2017-09-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of different dose
regimens of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia
(CLL).